MOH — authorised 12 December 1995
- Marketing authorisation holder: COVIS PHARMA SARL
- Status: likely_approved
🇮🇱 Rilutek in Israel
MOH authorised Rilutek on 12 December 1995
Marketing authorisation
Rilutek in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Israel
Frequently asked questions
Is Rilutek approved in Israel?
Yes. MOH authorised it on 12 December 1995.
Who is the marketing authorisation holder for Rilutek in Israel?
COVIS PHARMA SARL holds the Israeli marketing authorisation.